Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001085940 | SCV000558478 | benign | Brugada syndrome | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000463743 | SCV000716685 | likely benign | not provided | 2020-04-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000463743 | SCV001153922 | likely benign | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | SCN10A: BP4, BP7, BS1 |
Ambry Genetics | RCV002356737 | SCV002655494 | likely benign | Cardiovascular phenotype | 2019-05-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000463743 | SCV005260692 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000608988 | SCV005886799 | benign | not specified | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000608988 | SCV001923945 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000463743 | SCV001956617 | likely benign | not provided | no assertion criteria provided | clinical testing |